BRIEF published on 10/30/2025 at 21:05, 7 months 8 days ago Rapport semestriel et restructuration financière de TME Pharma Résultats Financiers Biotechnologie Emission D'obligations Nomination Du PDG TME Pharma
BRIEF published on 10/30/2025 at 21:05, 7 months 8 days ago TME Pharma's Semi-Annual Report and Financial Restructuring Financial Results Biotechnology CEO Appointment Bond Issuance TME Pharma
PRESS RELEASE published on 10/30/2025 at 21:00, 7 months 8 days ago TME Pharma publishes its semi annual results and half-year report TME Pharma publishes semi annual results and half-year report showing cost reductions, new CEO, and fundraising activities. Focus on NOX-A12 and NOX-E36 assets Fundraising Cost Reductions TME Pharma NOX-A12 Semi Annual Results
PRESS RELEASE published on 09/01/2025 at 08:45, 9 months 6 days ago Inside Information: Other news releases TME Pharma completes August financing, with €500k cash received on August 28th, bringing cash position to €2.35M. Organization aims to attract financing for cancer and eye therapies Cash Position TME Pharma August Financing Cost-efficient Organization Novel Therapies
BRIEF published on 09/01/2025 at 08:45, 9 months 6 days ago TME Pharma successfully completes its August fundraising round Biotechnology Fundraising Treasury Cryptocurrencies Cancer
BRIEF published on 09/01/2025 at 08:45, 9 months 6 days ago TME Pharma conclut avec succès sa levée de fonds d'août Biotechnologie Trésorerie Levée De Fonds Cryptomonnaies Cancer
PRESS RELEASE published on 09/01/2025 at 08:40, 9 months 6 days ago Informations privilégiées:Autres communiqués TME Pharma finalise une levée de fonds de 500 k € en espèces en août, atteignant une trésorerie de 2,35 M € pour développer de nouvelles thérapies contre le cancer et les maladies oculaires Trésorerie Levée De Fonds Cancer TME Pharma Thérapies
BRIEF published on 08/25/2025 at 08:05, 9 months 13 days ago TME Pharma obtient 500 000 € grâce à une nouvelle émission obligataire Stratégie Financière Stratégie D'investissement Emission D'obligations Réduction Des Coûts Engagements Des Actionnaires
BRIEF published on 08/25/2025 at 08:05, 9 months 13 days ago TME Pharma Secures €500,000 through New Bond Issue Investment Strategy Cost Reduction Bond Issuance Financial Strategy Shareholder Commitments
PRESS RELEASE published on 08/25/2025 at 08:00, 9 months 13 days ago Inside Information / Other news releases TME Pharma to raise €500k through bond issue & receives new shareholding notice. CEO & Chairman also invest. Funds to boost financial position & support R&D projects & investment strategy Fundraising Shareholding CEO Bond Issue TME Pharma
Published on 06/06/2026 at 04:45, 1 day 20 hours ago Battery X Metals Announces Closing of First Tranche of Private Placement to Advance Corporate Growth
Published on 06/06/2026 at 00:00, 2 days 1 hour ago Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program
Published on 06/05/2026 at 17:00, 2 days 8 hours ago Silver Spruce Resources Inc. Provides an Update on the Jackie Project Acquisition
Published on 06/05/2026 at 15:00, 2 days 10 hours ago Norsemont Drills 20 Meters of 1.20 G/T Gold Equivalent at Bottom of Hole
Published on 06/05/2026 at 13:30, 2 days 11 hours ago CANEX Announces Gold Basin Resources Shareholders Approve Merger Arrangement With CANEX With 75.82% Support
Published on 06/07/2026 at 21:24, 3 hours 56 minutes ago EQS-Adhoc: Readcrest Capital AG: Management Board issues forecast for adjusted EBITDA in 2026
Published on 06/07/2026 at 18:53, 6 hours 26 minutes ago Marley Spoon Group SE: Successful refinancing and leadership transition
Published on 06/07/2026 at 18:40, 6 hours 39 minutes ago EQS-Adhoc: Marley Spoon Group SE: CEO Resigns; Interim CEO Appointed
Published on 06/07/2026 at 10:55, 14 hours 25 minutes ago Bybit Launches IPO Express, Becoming One of First Centralized Crypto Exchanges to Offer Tokenized IPO Access, Starting With SpaceX
Published on 06/06/2026 at 08:29, 1 day 16 hours ago Starting today, Trade Republic gives European retail investors direct access to IPOs
Published on 06/05/2026 at 19:00, 2 days 6 hours ago ALTAREA - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 06/05/2026 at 19:00, 2 days 6 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 06/05/2026 at 19:00, 2 days 6 hours ago ALTAREIT - Descriptif du programme de rachat d'actions autorisé par l'assemblée générale mixte du 4 juin 2026 et mis en œuvre par la Gérance
Published on 06/05/2026 at 19:00, 2 days 6 hours ago ALTAREA : Descriptif du programme de rachat d'actions autorisé par l'assemblée générale mixte du 4 juin 2026 et mis en œuvre par la Gérance
Published on 06/05/2026 at 19:00, 2 days 6 hours ago ALTAREIT - DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES MAI 2026
